A retrospective study of efficacy of galcanezumab for the treatment of episodic or chronic migraine in adolescents
Latest Information Update: 04 Aug 2022
At a glance
- Drugs Galcanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
Most Recent Events
- 04 Aug 2022 New trial record
- 12 Jun 2022 Results presented at the 64th Annual Scientific Meeting of the American Headache Society